Dorzolamide And Timolol Solution
Product Images NDC 69315-305

14 FDA label images from Leading Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Dorzolamide And Timolol (NDC 69315-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 01)

A (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 01)
A text panel showing experimental conditions: temperature at 25°C, solvent as water with concentration C=1, wavelength of 405 nm, and a measurement result approximately -17°.*
FDA Label Image

C (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 02)

C (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 02)
Chemical structure of Dorzolamide Hydrochloride, the active ingredient in Dorzolamide and Timolol Ophthalmic Solution. The diagram shows the molecular arrangement including sulfonamide groups and the hydrochloride component.*
FDA Label Image

B (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 03)

B (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 03)
Chemical structure diagram of Dorzolamide Hydrochloride, showing molecular geometry and bond angles at 25°C with specific measurements in 1N HCl.*
FDA Label Image

F (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 04)

F (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 04)
Chemical structure diagram showing the molecular components of Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution. The diagram includes structural formulas with annotated atoms and chemical bonds relevant to the active ingredients.*
FDA Label Image

I (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 05)

I (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 05)
A small clear plastic bottle with a white label containing unreadable black text blocks. The bottle has a white and blue cap and is designed for ophthalmic solution use. The label indicates it is a pharmaceutical product, likely the Dorzolamide and Timolol ophthalmic solution. The bottle is shown as it would be received, sealed with the protective cap.*
FDA Label Image

Fig 2 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 06)

Fig 2 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 06)
An instructional illustration showing a hand holding a small ophthalmic solution bottle with a dust cover on top. The image includes an arrow indicating to turn the dust cover clockwise to snap it off and break the seal, demonstrating how to open the bottle.*
FDA Label Image

Fig 3 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 07)

Fig 3 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 07)
An instructional illustration showing hands removing the dust cover from a small ophthalmic solution bottle labeled with text. The bottle has a purple cap and is held upright against a blue background. An arrow indicates the direction to pull off the dust cover.*
FDA Label Image

Fig 4 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 08)

Fig 4 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 08)
An instructional image showing hands holding a small ophthalmic solution bottle with a blue cap being unscrewed. The label on the bottle contains illegible text. The image includes an arrow indicating the twisting motion to remove the cap and the text "Unscrew the blue coloured cap."*
FDA Label Image

Fig 5 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 09)

Fig 5 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 09)
An instructional illustration showing how to properly administer ophthalmic solution drops. A person tilts their head backward and pulls down the lower eyelid slightly to create a pocket between the eyelid and eye. The other hand holds a dropper bottle dispensing eye drops with gentle pressure. The instructions guide proper application for ophthalmic solution use.*
FDA Label Image

Fig 6 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 10)

Fig 6 (Be87baf2 Ac60 4540 8cf2 1d6be01acff8 10)
An instructional illustration showing hands holding an ophthalmic solution bottle with a blue cap. The image includes a directive to replace the cap after every use and to screw the blue colored cap down securely.*
FDA Label Image

Container5ml (Container5ml)

Container5ml (Container5ml)
The label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, USP, showing a 5 mL solution with concentrations of 22.3 mg/mL and 6.8 mg/mL respectively. The label includes product and manufacturing details, batch code area, expiration, and usage instructions, with Leading Pharma, LLC as the manufacturer and an NDC of 69315-305.*
FDA Label Image

Carton5ml (Carton5ml)

Carton5ml (Carton5ml)
Packaging label for Dorzolamide HCl and Timolol Maleate Ophthalmic Solution USP, 22.3 mg / 6.8 mg per mL, in a 5 mL bottle by Leading Pharma. The label includes NDC 69315-305-05, usage instructions with illustrations for opening and dispensing drops, storage conditions, manufacturing information, and a partial eye image.*
FDA Label Image

Container10ml (Container10ml)

Container10ml (Container10ml)
Label for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, USP, 22.3 mg / 6.8 mg per mL, 10 mL solution for topical eye administration. The label includes NDC 69315-305-10, manufacturer information (FDC Limited, India), and labeler Leading Pharma, LLC of Fairfield, NJ. It contains usage instructions, storage advice to protect from light, and barcodes.*
FDA Label Image

Carton10ml (Carton10ml)

Carton10ml (Carton10ml)
Packaging label for Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 22.3 mg/6.8 mg per mL, 10 mL solution. The label includes usage instructions with illustrations, storage conditions, and manufacturer information: Leading Pharma, LLC, Fairfield, NJ, with the product made in India by FDC Limited. The label also highlights that the product is sterile, contains inactive ingredients, and includes a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.